Cargando…
Drug safety monitoring in patients of movement disorders of a tertiary care hospital
BACKGROUND: Movement disorders (MD) are neurological conditions that affect the speed, fluency, quality, and ease of movement and commonly include Parkinson’s disease, tremor and dystonias. Drugs are important causes of MD, and the incidence and prevalence of such disorders are possibly underappreci...
Autores principales: | Mandal, Ananya, Chatterjee, Suparna, Das, Shyamal Kumar, Mishra, Amar |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941620/ https://www.ncbi.nlm.nih.gov/pubmed/20927255 http://dx.doi.org/10.4103/0253-7613.68437 |
Ejemplares similares
-
Clinical effectiveness and safety of low cost versus innovator brand amlodipine in hypertension: A single-blinded, randomized, crossover, noninferiority trial
por: Das, Alak Kumar, et al.
Publicado: (2016) -
Clinical effectiveness and safety of escitalopram and desvenlafaxine in patients of depression with anxiety: A randomized, open-label controlled trial
por: Maity, Nabakumar, et al.
Publicado: (2014) -
Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis
por: Ghosh, Ritwik, et al.
Publicado: (2021) -
Knowledge of Parkinson's disease among patients and caregivers attending movement disorder clinic at a tertiary care centre in north India
por: Yadav, Ravi, et al.
Publicado: (2012) -
Wearable sensors for the monitoring of movement disorders
por: Jalloul, Nahed
Publicado: (2018)